Tong Ren Tang
Tong Ren Tang specalized in traditional Chinese medicine and therapy.
Tong Ren Tang, founded in 1669 and headquartered in Beijing, is a leading Chinese pharmaceutical company. As a subsidiary of Beijing TRT Group, the company was listed on the Shanghai Stock Exchange in 1997. Rivals with direct and indirect competition include Pientzehuang Pharmaceutical, Yunan Baiyao, and Dong-E-E-Jiao.
Intracardiac Echocardiography Enterprise, Cardioacc, Wins Angel Round Financing
Shuidi company has established a new pharmaceutical innovation division to further develop the pharmaceutical direction
Yi Ming ang Ke delivers a statement to the main board of the Hong Kong stock exchange to develop a new generation of tumor immunotherapy
Fosun pharma and Amgen have reached cooperation to accelerate the commercialization of two innovative drugs in China
F-star to be acquired by China biopharmaceutical with USD 161million
"Delisting warning" of Whitson pharmaceuticals on the New York Stock Exchange
East China medicine "liraglutide" goes to sea
SINOVAC Plans to Invest USD 100 Mn in Brazil Starting This Year
EqualOcean has learned that on June 4, Vice President of the Federative Republic of Brazil and Minister of Development, Industry, Trade, and Services, Geraldo Alckmin, met with SINOVAC(科兴) Chairman, President, and CEO Yin Weidong(尹卫东) in Beijing.
Jun 06, 2024 06:18 PM
Yunnan Baiyao: An Oriental Mystery in the Limelight (2/2)
Tagged as ‘China’s Time-honored Brand,’ Traditional Chinese Medicine (TCM) company Yunnan Baiyao (000538:SZ) has come to an unprecedented crossroads after fulfilling the challenge of pushing TCM to the foreground.
May 19, 2020 12:30 PM
Yunnan Baiyao: An Oriental Mystery in the Limelight (1/2)
Tagged as ‘China’s Time-honored Brand,’ Traditional Chinese Medicine (TCM) company Yunnan Baiyao (000538:SZ) has come to an unprecedented crossroads after fulfilling the challenge of pushing TCM to the foreground.
May 19, 2020 12:00 PM
Chinese medicine stocks recovered significantly in the afternoon
Pharmaceutical and biological stocks continued to strengthen in the afternoon
State Food and Drug Administration: Yitong Biotechnology (Guangzhou) Co., Ltd. stopped production for rectification